Upamostat
PC06
Phase 2 small_molecule completed
Quick answer
Upamostat for SARS-CoV-2 is a Phase 2 program (small_molecule) at RedHill Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- RedHill Biopharma
- Indication
- SARS-CoV-2
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed